342 participants
A 24-Week Study to Evaluate the Safety and Efficacy of ADVAIR DISKUS® Inhaler 250/50mcg Plus SPIRIVA HANDIHALER® Inhaler Versus SPIRIVA HANDIHALER® Inhaler Plus Placebo DISKUS® Inhaler in Subjects With Chronic Obstructive Pulmonary Disease (COPD).
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2016-11-23
- Start Date:
- 2008-12-31
- Completion:
- 2009-12-31
Conditions
- Pulmonary Disease, Chronic Obstructive
Interventions
- DRUG